PT Prodia Widyahusada TbkPRWDF 77 EBIT per Share is $0.02 as of Mar. 2026. GuruFocus rates PRWDF with a GF Score™ of 77/100. The stock has 2 warning signs investors should review. Among 169 Medical Diagnostics & Research companies, PT Prodia Widyahusada Tbk ranks worse than 83.43% on this metric.
PT Prodia Widyahusada Tbk's EBIT per Share for the
three
months ended in Mar. 2026 was $0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.02.
During the past 12 months, the average EBIT per Share Growth Rate of PT Prodia Widyahusada Tbk was -0.90% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -19.30% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -12.10% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 12.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for PT Prodia Widyahusada Tbk's EBIT per Share or its related term are showing as below:
PRWDF'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -27 Med: 15.4 Max: 61.8
Current: -19.3
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of PT Prodia Widyahusada Tbk was 61.80% per year. The lowest was -27.00% per year. And the median was 15.40% per year.
PRWDF's 3-Year EBIT Growth Rate is ranked worse than 83.43% of 169
companies
in the Medical Diagnostics & Research industry
Industry Median: 12.5
vs PRWDF: -19.30
PT Prodia Widyahusada Tbk (OTCPK:PRWDF) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
PT Prodia Widyahusada Tbk EBIT per Share Related Terms
PT Prodia Widyahusada Tbk EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Prodia Widyahusada Tbk (PRWDF) has a EBIT per Share of $0.02 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on PT Prodia Widyahusada Tbk and its competitors. According to the industry distribution chart, PT Prodia Widyahusada Tbk ranks #141 out of 169 companies in the Medical Diagnostics & Research industry, placing it in the top 83.4%.
Is PT Prodia Widyahusada Tbk's EBIT per Share too high?
PT Prodia Widyahusada Tbk's current EBIT per Share is $0.02. The Medical Diagnostics & Research industry median EBIT per Share is 12.50. PT Prodia Widyahusada Tbk's value of $0.02 is 99.8% below this industry median. Based on the distribution chart, PT Prodia Widyahusada Tbk ranks #141 out of 169 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, PT Prodia Widyahusada Tbk has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does PT Prodia Widyahusada Tbk's EBIT per Share compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, PT Prodia Widyahusada Tbk ranks #141 out of 169 companies for EBIT per Share. This places PT Prodia Widyahusada Tbk in the lower half of its industry. The industry median EBIT per Share is 12.50. PT Prodia Widyahusada Tbk's value of $0.02 is 99.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Diagnostics & Research company?
The median EBIT per Share among Medical Diagnostics & Research companies is 12.50, based on 169 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Prodia Widyahusada Tbk's current EBIT per Share of $0.02 is 99.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on PT Prodia Widyahusada Tbk and its competitors. For the Medical Diagnostics & Research industry, the median EBIT per Share is 12.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Prodia Widyahusada Tbk's current EBIT per Share is $0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Prodia Widyahusada Tbk stock overvalued right now?
PT Prodia Widyahusada Tbk (PRWDF) has a current EBIT per Share of $0.02. The current EBIT per Share is $0.02 and 99.8% below the Medical Diagnostics & Research industry median of 12.50. PT Prodia Widyahusada Tbk's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For PT Prodia Widyahusada Tbk (PRWDF), the current EBIT per Share is $0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Prodia Widyahusada Tbk provides health care testing services. The company provides analytic and diagnostic services for the medical professionals. It is engaged in health laboratories by conducting business activities such as setting up clinics, health laboratories, management of hospitals, and health checkup services. Its operating segments are Central: Jakarta; Sumatera: Sumatera, Kepulauan Riau; Greater Jakarta: Jakarta, Bogor, Depok, Tangerang, Bekasi, Lampung, Pangkal Pinang; West Java; Central Java; East Java, Bali, Nusa Tenggara; Kalimantan Sulampua: Kalimantan, Sulawesi, Ambon, Papua.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRWDF has been successfully added to your 